Prosus’s red report card for underperformers Byju’s, PharmEasy

This is the third time Prosus has marked down its valuation of the beleaguered edtech firm within a year.

30 November, 20231 min
0
Prosus’s red report card for underperformers Byju’s, PharmEasy

You may also like

Business
Story image

United Spirits needs some animal spirits

The country’s largest liquor company just announced solid Q3 numbers. It has a product portfolio its peers envy. Its advertising budget is the largest. Yet, it’s the worst performing liquor stock.

Business
Story image

SBI Funds Management’s run-up to an IPO is too messy, too expensive

Low profitability, lagging metrics and a lack of succession planning are expected to weigh heavily on the proposed stock market debut of India’s largest asset management company.

Business
Story image

New complications for sovereign funds in the US

The American government proposed threatening tax tweaks, a local fintech raised a quarter of a billion dollars in seed money and open finance made a start.